Atlas Trials

Introgen Therapeutics

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Introgen Therapeutics

RecordFirmDate
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma (NCT00116363)Introgen Therapeutics2005-03-01
Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer (NCT00044993)Introgen Therapeutics2002-02-01
Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone (NCT00041626)Introgen Therapeutics
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate (NCT00041613)Introgen Therapeutics
Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer (NCT00286247)Introgen Therapeutics

Track Introgen Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.